Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anx007 (2 trials)
lenvatinib (lenvima) (2 trials)
pembrolizumab (keytruda) (2 trials)
dexamethasone (1 trial)
eg-301 (1 trial)
memantine (namenda) (1 trial)
nitazoxanide (Alinia) (1 trial)
Pneumonia (Phase 2)
Trials (5 total)
Trial APIs (7 total)